Gamma Biosciences Mergers & Acquisitions

Gamma Biosciences M&A Summary

Gamma Biosciences has acquired 3 companies, including 3 in the last 5 years. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2024, when it sold Mirus Bio to MilliporeSigma for $600M. Gamma Biosciences has acquired in 3 different US states. The Company’s most targeted sectors include life science (67%) and test/measurement equipment (34%).

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity3
    • M&A Sell Activity1
  • Total Sectors Invested 2
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

Gamma Biosciences

Gamma Biosciences

2800 Sand Hill Road, #200,
Menlo Park, California 94025
United States,
www.gammabiosciences.com

All (4) Buy (3) Sell (1)
Date Target Value
$mlns
Transaction Type Acquirer Seller SRC
Link
2024-05-22 Mirus Bio · Life Science
Madison, Wisconsin · www.mirusbio.com

Mirus Bio is a developer of biomimetic, cell-adaptive lipid-polymer nanocomplexes (LPNCs) for nucleic acid delivery. Mirus Bio's expertise in nucleic acid delivery gives life scientists the most advanced tools for gene expression, biotherapeutic protein production, virus manufacturing, and genome editing. Mirus Bio was founded in 1995 and is based in Madison, Wisconsin.

600 Divestiture

MilliporeSigma

Gamma Biosciences


Try Mergr Free — See This and 221,377+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.